One-year Analysis of Efficacy and Safety Data from Black/African American and Hispanic/Latino People with Relapsing Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial (PL5.005)
Neurology(2024)
摘要
CHIMES (NCT04377555) was designed to evaluate the efficacy and safety of ocrelizumab in Black/African American and Hispanic/Latino people with relapsing multiple sclerosis (BpwRMS; HpwRMS).
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要